<DOC>
	<DOCNO>NCT01694511</DOCNO>
	<brief_summary>The purpose study determine whether High Resolution Magnification Endoscopy ( HRME ) Computed Virtual Chromoendoscopy ( CVC ) target biopsy superior conventional white light endoscopy ( WLE ) 4 quadrant biopsy metaplastic epithelium every 1-2 cm ( Seattle Protocol ) detection pre-malignant lesion patient Barrett 's Esophagus ( BE ) .</brief_summary>
	<brief_title>Endoscopic Detection Dysplasia Barrett 's Esophagus</brief_title>
	<detailed_description>BE metaplastic mucosal transformation adjacent esophagogastric junction , due chronic reflux gastric juice , Gastro Esophageal Reflux Disease ( GERD ) . The continuous esophageal exposure acid- and/or bile- contain fluid lead , untreated , chronic esophagitis . In certain patient mucosal transformation take place . The epithelium distal part esophagus transfer squamous intestinal-like mucosa , call Specialized Intestinal Metaplasia ( SIM ) .Patients BE believe run high risk develop esophageal adenocarcinoma ( EAC ) . EAC rare condition western society , prevalence rise compare malignancy , substantial increase see last four decade . The pathogenesis cancer development believe SIM patient undergo dysplastic transformation , low high grade , high grade dysplasia ( HGD ) develop AC . Advanced EAC associate poor prognosis whereas HGD carcinoma situ may treat endoscopically favorable outcome . The need surveillance endoscopy order discover early cancer lesion available curable treatment cost effectiveness evidence level regard screen . The conventional endoscopic ( CE ) surveillance algorithm BE standard WLE 4 quadrant biopsy metaplastic epithelium every 1-2 cm esophagogastric junction . The development advance endoscopic technique make possible distinguish minimal polypoid lesion also microvasculature pit-pattern structure certain grade system associate presence dysplasia . Attempts make explore benefit advance endoscopic technology standard WLE . Feasibility-studies suggest new technique improve biopsy-yield dysplasia , however limited number prospective study exist . Study aim : To determine whether HRME CVC target biopsy superior conventional WLE 4 quadrant biopsy metaplastic epithelium every 1-2 cm ( Seattle Protocol ) detection pre-malignant lesion patient BE . Primary endpoint : Incidence detect dysplasia endoscopic technique . Secondary endpoint : 1.The yield low- and/or high-grade dysplasia endoscopic technique . 2.The number biopsy take duration different endoscopic technique . 3.The endoscopic prediction capability present dysplasia compare histopathology HRME . Statistical power : Based primary endpoint , amount dysplasia Barrett-population approximately 10 % . We calculate raise positive yield use advanced endoscopy 8 % . At p &lt; 0,05 power 80 % need 105 patient . Setting : Tertiary referral high volume endoscopy center Sahlgrenska University Hospital , Sweden .</detailed_description>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>Presence specialize intestinal metaplasia biopsy esophagus Dysplasia cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Endoscopy , Gastrointestinal</keyword>
</DOC>